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Abstract 
Although the treatment of patients with renal failure using hemodialysis services is not as expensive as kidney 
transplant, but because it has to be done continuously the cost of this treatment becomes very expensive. Cost 
analysis is required to know all the details of the costs to be incurred and used. Hemodialysis service unit is one 
of the services that is quite expensive, because it is influenced the price of medical supplies, drugs and 
consumables. Meanwhile, along with the increasing number of patients with kidney failure, the number of 
dialysis patients more and more. The problem that occurs today is when the number of patients and facilities are 
limited, so many patients who have to queue for dialysis. Because these limitations are difficult to overcome by 
the ability of government and community funding, the use of resources should be as efficient as possible. This 
study to determine the impact of treatment therapy patients who experience kidney failure hemodialysis based 
on cost effectiveness analysis approach. This study is an analytical study to see the therapy of patients 
undergoing hemodialysis with body mass index of patients with renal failure. This research has been done in 
unit hemodialysis RSWS UNHAS Makassar, by using sampling technique consecutive sampling counted 60 
respondents. Variables in this study were age, sex, frequency of hemodialysis, body mass index and long 
undergoing hemodialysis. Through CEA financing handling for patients with renal failure who perform 
hemodialysis actions can effectively have a positive impact. This is because cost-effectiveness analysis or CEA 
is a method designed to compare health outcomes and costs used to implement programs or interventions with 
other alternatives that produce the same outcomes. 
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1. Introduction 
Mortality in patients with chronic kidney disease (CKD), especially those undergoing hemodialysis is very high. 
The death of CKD patients can be caused by a variety of things: excess fluid volume (overload volume), 
metabolic acidosis, electrolyte balance disorder especially hyperkalemia as well as infection (sepsis), but 40-
45% of deaths are caused by cardiovascular complications1. Kidney disease is a problem of the field of 
nephrology with the incidence rate is still quite high, the etiology is broad and complex, often begins without 
complaints or clinical symptoms unless it has reached the terminal stage (terminal renal failure) [2]. 
In the United States, in 2008 the incidence of kidney failure reached 547,982 patients, and this number 
continues to increase every year3. In other developing countries, the incidence is estimated to be around 40-60 
cases per million people per year. The 2010 data show that 59% of deaths in Indonesia are caused by non-
communicable diseases, which require enormous medical expenses, one of which is renal failure [4]. Indonesia 
is a country with high rates of renal failure. The increase of this disease patient in Indonesia reached 20% 
[2,5,6]. 
Kidney failure is now the concern of the health world for several reasons [12-13], namely the rapid increase of 
prevalence, the high cost of the treatment process, the iceberg phenomenon that covers the veiled disease, and 
plays an important role in increasing the risk of other diseases and the discovery of effective measures To 
prevent disease progression [7,8,10]. The direct effect of the cost of kidney failure is also reported that there has 
been an increase in total cost as much as 38% to higher with the largest cost component being the cost of care 
and medicine [11,12,13]. 
The kidneys have a role and function to regulate the fluid balance in the body, regulate the concentration of salt 
in the blood, the acid base balance in the blood and the excretion of waste materials such as urea and other 
nitrogen trash in the blood [13-15]. When the kidneys are not able to work properly then there will be health 
problems that will be associated with kidney failure [16,17,18].Kidney Failure consists of two forms of Acute 
Renal Failure (GGA) and Chronic Kidney Failure (GGK) [19,20,21].It is said Acute if the disease develops very 
quickly, occurring within hours or within days22-23. While Chronic occurs and develops slowly for several 
years24. ARF is a sudden decrease in renal function with the loss of the kidney's ability to maintain body 
homeostasis [25-26]. ARF is also a syndrome that is marked by a sudden decline in kidney function with the 
result of augmenting metabolic compounds of nitrogen such as urea and creatinine [27-30] 
In Indonesia alone, there are two options for undergoing renal replacement therapy, namely hemodialysis (HD) 
and peritoneal dialysis (DP) [31,32,33].However, constraints on peritoneal dialysis programs in Indonesia such 
as (1) peritoneal dialysis cost per month are still more expensive than hemodialysis and (2) environmental 
sanitation and educational levels for most patients are factors that do not support this program, making 
hemodialysis as a replacement therapy choice program Main kidney34,35,36. Hemodialysis patients get special 
attention from the government because most of the hemodialysis patients are productive patients aged between 
20-60 years [37,38,39]. With a decrease in kidney function, or even failure, not only decreased quality of life, 
lifelong treatment also cost [40-41]. 
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One way or action taken in cost-effective utilization in patients undergoing hemodialysis therapy from the point 
of utilization of economic value through Cost Effectiveness Analysis by means of reuse is used in more than 
80% dialysis centers in the United States [42,43,44]. The process of repeating dialyzer for patients is proven 
safe and clearance characteristics of analyzed reuse does not change if the dialyzer cleaning process is 
implemented correctly [45,46,47]. Reuse in addition to cost saving, can also increase biocompatibility and 
reduce the frequency of first use syndrome in hemodialysis patients [48,49,50]. However, in the implementation 
of cost effectiveness in the health financing process, especially concerning the financing of renal failure therapy 
and hemodialysis has its own handling process of each action performed50-54. The process of hemodialysis is a 
complicated process of health services that require special nurses to carry out this service [55-57.]In addition, 
hemodialysis service (dialysis) is one of the services that are quite expensive, because it is influenced by the 
price of medical supplies, drugs and consumables that are heavily influenced by the current monetary crisis58-
61. Indonesia's health financing system that is still out of pocket and has not accumulated insurance thoroughly, 
causing patients with kidney failure, especially the poor in Indonesia becomes increasingly powerless [62-65]. 
Therefore, it is necessary to control the cost of health services (cost containment) which is changed from the 
form of fee for service to the form of Prospective Payment System (PPS) [66-70]. Research in several European 
countries especially relating to patients with kidney failure that is expressing the model of payment through Cost 
Effectiveness Model with system of Diagnosis Related Group (DRG) including one of payment system of 
prospective payment system that is a payment system at health service provider, either hospital or doctor, In the 
amount prescribed prior to the medical service is provided in accordance with the diagnosis of the disease, 
whatever will be done to the patient concerned including duration of hospital care [71-73]. 
Hospitals that grow and develop must be managed efficiently and effectively, it is necessary to face the tough 
competition in the world of health [74-76]. Hospitals can survive in the existing competitions, of course, the 
hospital must recalculate the existing hospital rates, namely to minimize the calculation of tariffs are so high by 
using a competitive tariff calculation model, although with low tariffs but still uphold a quality To be able to run 
the vision and mission of a hospital, so that the hospital does not suffer losses in terms of rates and customer 
[77-79]. This is done to draw interest back old patients and new patients in utilizing existing services80-85. 
Cost effectiveness from the demand side is to impose cost contributions [86-87]. The motivation behind the 
application of fee fees is the assumption that high demand for health services is a major cause of the high cost of 
health [88-89]. 
In connection with the above, effective payment system mechanism through Cost Effectiveness Analysis 
approach in the process of handling patients with kidney failure and hemodialisa90-93 treatment, where the 
payment system will encourage health providers including doctors and hospitals to make efficient health 
facilities And selection of appropriate therapeutic guidelines so as to lower the length of stay (LOS) [95-97]. In 
addition, it also helps clinicians in improving services, assisting in understanding resource use and creating a 
more equitable allocation of resources, improving efficiency in serving patients and providing comparative 
information between hospitals [98-102]. 
Based on the above phenomenon, and some studies that have been done to describe patients with kidney failure 
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experienced many changes in his life, especially concerning the issue of financing. To answer and address the 
phenomenon, the authors are interested to raise the topic of further research on the impact of hemodialysis 
treatment therapy for patients with renal failure based on Cost Effectiveness Analysis.  Cost effectiveness 
analysis is an evaluation considering the cost and consequence aspects of an alternative problem solving. It is a 
decision-making tool designed for decision makers to know with certainty the most efficient solving option 
[14,43,60]. It is further disclosed that cost effectiveness is a model used to assess the most appropriate decision 
alternatives by comparing such alternatives in relation to the finances to be sacrificed [68,71,73]]. In the First 
Principles of Cost Effectiveness Analysis in Health, the CEA is a method for determining which programs can 
accomplish a particular goal at a minimum cost [43, 64, 65]. 
Cost Effectiveness Analysis or CEA is a method designed to compare the health outcome and the costs used to 
implement the program or interventions with other alternatives that produce the same outcomes [92,96,98]. 
Health outcomes are expressed in objective and measurable terms such as number of treated cases, decreased 
blood pressure expressed in mmHg, and others and not in monetary terminology [60,91,92]. 
Cost effectiveness analysis is one way to select and rate the best program when there are several different 
programs with the same goals available to choose [99,100]. Which criteria of the assessment will be chosen 
based on the discounted unit cost of each alternative program so that the program has the lowest discounted unit 
cost that will be chosen by the analysis / decision maker [93,99,101].Based on the above reviews, Cost 
Effectiveness Analysis is one form of economic evaluation of health programs to determine which programs are 
more efficient, both in terms of the achievement of the objectives and in terms of costs [42,43,102].Kidney 
failure is basically a condition in which kidney function decreases so that it can no longer do the filtration of the 
body's remaining metabolism and maintain electrolyte fluid balance such as sodium and potassium in the blood 
or urine [1,8,12]. This disease continues to grow slowly until the kidney function gets worse until the kidney 
loses its function [32,40,89].Kidney failure occurs when sudden renal function decreases 40. The most 
important function of the kidneys is to remove electrolytes and excess water in the filtered blood every 40.106 
seconds. Liquids and electrolytes, acidic and alkaline substances present in the blood should always be in a 
balanced state [81,101]. Kidney tasks one of them that at all times maintain that balance 
[37,40,106].Replacement therapy that can be performed in patients with end-stage renal failure is with 
hemodialysis, peritoneal dialysis and renal transplant [32,106]. Renal transplantation has been a worldwide 
hemodialysis therapy [25,31,37]. The benefits of transplant have clearly proven to be better than hemodialysis 
especially in terms of improving patient's quality of life [106]. This therapy is the most ideal therapy, because it 
overcomes all types of decline in kidney function, On the other hand hemodialysis and peritoneal dialysis just 
overcome the effects of some types of kidney function decline so that patients have a high degree of dependence 
on this action [25,40,106]. 
2. Materials and Method 
This research is an analytic research to see the impact of therapy of patients undergoing hemodialysis with body 
mass index of patients with chronic renal failure in RSWS UNHAS Makassar 2016. This research has been done 
in unit hemodialysis RSWS UNHAS Makassar, using sampling technique consecutive sampling as much as 60 
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respondents [118- 119]. Variables in this study were age, sex, frequency of hemodialysis, body mass index and 
long undergoing hemodialysis. 
3. Results  
The impact of hemodialysis therapy, clients with long-term hemodialysis often feel worried about unpredictable 
illness conditions and disruptions in life. They usually face financial problems, difficulties in keeping jobs, 
disappearing sexual urges and impotence, depression caused by chronic pain and fear of death. Young clients, 
they fear their marriages, their children and the burden they inflict on their families. The lifestyle of 
hemodialysis clients and restrictions on food intake and fluids often deprive the life span of the client and his 
family. This is as a stressor for the client. Based on this, restrictions on food and fluid intake can be explained as 
the following figure: 
 
Figure 1. The comparison between hemodialisis and non hemodialisis patient water intake  
Patients with renal failure both before and after hemodialysis therapy tend to experience fluid volume 
fluctuations. In some studies it has been suggested that routine hemodialysis patients, fluctuations or excess 
fluid are caused by decreased renal function in fluid expression and lack of patient adherence in limiting patient 
fluid intake. Although patients with chronic renal failure early in HD have been given health counseling to 
reduce fluid intake during the day, but in the next HD therapy is still often the case patients who do not follow 
the advice given. 
The success of hemodialysis depends on patient compliance. Various researches on patient compliance with 
chronic renal failure who received hemodialysis therapy obtained varying results. In general, non-adherence of 
dialysis patients included 4 (four) aspects of non-compliance following hemodialysis program (0% -2.3%), non-
compliance in treatment program (1.2% -81%), non-compliance with fluid restriction (3.4% 74%) and non-
adherence following the diet (1.2% -82.4%). Reportedly more than 50% of patients undergoing hemodialysis 
therapy are not adherent in the restriction of fluid intake primarily in the pattern of daily habits by drinking soft 
drinks, tea and coffee. 
With the duration of therapy, and performed routinely every week resulting in patients in their daily lives 
disrupted so that the problem becomes accumulate. Stacking the problem causes the patient to experience 
depression/stress. Depression/stress is a feeling of sadness experienced by all people and can affect the activity, 
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diet, sleep, concentration and even have ideas for suicide. 
Table1. List of questions relate to hemodialysis patient period of treatment condition  
No Question 
Hemodialysis 
Yes No Total 
1 Do you undergo hemodialysis more than 1 year? 
20 30 50 
40,0% 60,0% 100,0% 
2 Do you regularly undergo HD 2x-3x every week? 
30 20 50 
60,0% 40,0% 100,0% 
3 Do you undergo hemodialysis within the specified time? 
36 14 50 
72,0% 28,0% 100,0% 
4 Do you need a long time to adapt to your current condition? 
30 20 50 
60,0% 40,0% 100,0% 
5 Can you adapt to your current condition within 1 year? 
31 19 50 
62,0% 38,0% 100,0% 
In the Hemodialis group, the 1st question is answered No by most respondents is 60.0%; Question 2 answered 
Yes by most respondents that is as much as 60.0%; Question 3 answered Yes by most respondents that is as 
much as 72.0%; Question 4 answered Yes by most respondents that is as much as 60.0%; Question 5 answered 
Yes by most respondents that is as much as 62.0%.Hemodialysis procedure is very beneficial for patients with 
renal failure, but it does not mean not risky and has no side effects. Various problems and complications can 
occur in patients undergoing hemodialysis hence required an adaptation process for patients in hemodialysis 
therapy. Hemodialysis complications can cause feelings of discomfort, increase stress and affect the quality of 
life of patients. Hemodialysis measures significantly affect or affect the quality of life of patients such as 
physical health, psychological, spiritual, socioeconomic status and family dynamics. 
Patients who experience automatic renal failure experience a decline in body function that causes the patient to 
feel useless that emotionally affects the interaction process with family, relatives, and others. This patient 
becomes disturbed, the patient becomes irritable and often closes himself in interacting. These conditions 
indicate that the patient has been depressed or stress. 
Hemodialysis patients have limited role in their life in the family and in the community. Hemodialysis therapy 
will reduce the patient's activity time, so as to cause conflicts in the patient's self or the role of the patient in 
social reduced. Most patients complain of routine hemodialysis activities interfere with work and daily 
activities. Researchers argue that social skills are felt to be severe by patients undergoing hemodialysis therapy, 
influenced by aspects of limitations including physical capacity, which can interfere with the work and activities 
of patients in the community. Conditions experienced by hemodialysis patients greatly affect the patient's 
economic conditions as can be explained in the following table: 
 
International Journal of Sciences: Basic and Applied Research (IJSBAR)(2017) Volume 33, No  3, pp 320-334 
326 
 
Table 2. List of questions relate to the hemodialysis and non hemodialysis patients period of 
treatment condition 
No Question 
Hemodialysis Non Hemodialysis 
Yes Non Total Yes Non Total 
1 
Do you agree with the cost of dialysis at this 
time 
15 35 50 9 39 48 
30,0% 70,0% 100,0% 18,8% 81,3% 100,0% 
2 
Do you feel comfortable in the treatment 
process 
20 30 50 21 27 48 
40,0% 60,0% 100,0% 43,8% 56,3% 100,0% 
3 
Are you given a healing alternative by the 
Doctor in the treatment process 
7 43 50 8 40 48 
14,0% 86,0% 100,0% 16,7% 83,3% 100,0% 
4 
Whether with the low-protein diet is cheaper 
than hemodialysis 
47 3 50 41 7 48 
94,0% 6,0% 100,0% 85,4% 14,6% 100,0% 
5 
With a low protein diet system is more effective 
than hemodialysis and peritoneal dialysis 
43 7 50 40 8 48 
86,0% 14,0% 100,0% 83,3% 16,7% 100,0% 
6 
Are you able and agree with the cost in the 
kidney transplant program 
1 49 50 1 47 48 
2,0% 98,0% 100,0% 2,1% 97,9% 100,0% 
7 
Is appropriate to the service you received 
during the treatment process 
39 11 50 32 16 48 
78,0% 22,0% 100,0% 66,7% 33,3% 100,0% 
8 
Do you get accurate cost information related to 
hemodialysis services 
40 10 50 40 8 48 
80,0% 20,0% 100,0% 83,3% 16,7% 100,0% 
9 
Have you been carrying out food intake 
according to the standards for patients 
undergoing treatment 
29 21 50 31 17 48 
58,0% 42,0% 100,0% 64,6% 35,4% 100,0% 
10 
Do you feel any objection to the low protein 
diet program? 
4 46 50 1 47 48 
8,0% 92,0% 100,0% 2,1% 97,9% 100,0% 
 
Figure: 2, Results relate to the hemodialysis patient period of treatment condition 
International Journal of Sciences: Basic and Applied Research (IJSBAR)(2017) Volume 33, No  3, pp 320-334 
327 
 
In the Hemodialis group, the 1st question is answered No by most respondents is 70.0%; Question 2 answered 
No by most respondents that is as much as 60.0%; The 3rd question answered Not by most respondents that as 
much as 86.0%; Question 4 answered Yes by most respondents that is as much as 94.0%; Question 5 answered 
Yes by most respondents that is as much as 86.0%; Question 6 answered No by most respondents that is as 
much as 98.0%; Question 7 answered Yes by most respondents that is as much as 78.0%; Question 8 answered 
Yes by most respondents that is as much as 80.0%; Question 9 answered Yes by most respondents that is as 
much as 58.0%; And the 10th question answered No by most respondents that is as much as 92.0%. 
In the Non Hemodialis group, the 1st question is answered Not by the majority of respondents ie 81.3%; 
Question 2 answered No by most respondents that is as much as 56.3%; 3rd question answered No by most 
respondents that is as much as 83.3%; Question 4 answered Yes by most respondents that is as much as 85.4%; 
Question 5 answered Yes by most respondents that is as much as 83.3%; Question 6 answered No by most 
respondents that is as much as 97.9%; Question 7 answered Yes by most respondents that is as much as 66.7%; 
Question 8 answered Yes by most respondents that is as much as 83.3%; Question 9 answered Yes by most 
respondents that is as much as 64.6 %%; And the 10th question answered No by most respondents that is as 
much as 97.9%. In the application of cost effectiveness analysis (CEA), estimates all cost information during 
hemodialysis treatment. The CEA here estimates the magnitude of useful information for decision makers with 
the alternatives of each of the health services it obtains 
Patients with renal failure who undergo hemodialis, require 12-15 hours for dialysis each week, or at least 3-4 
hours per treatment. This activity will last forever throughout his life. This is what takes the time and energy for 
patients with chronic renal failure who undergo hemodialysis therapy, so that there was a change, especially 
changes in the appearance of the role. The state of dependence on a lifetime dialysis machine as well as 
adjustment to sickness conditions result in changes in the patient's life. Changes in life is one of the triggers of 
stress. The change can be a variable identified as a stressor. 
Changes in life is one of the triggers of stress. The change can be a variable identified as a stressor. Patients 
usually face financial problems, difficulties in maintaining work or role appearances, disappearing sexual urges 
and impotence, worrying about marriage and fear of death. The occurrence of stress because of the perceived 
and perceived stressor of an individual, is a threat that can cause anxiety. Changes experienced in hemodialysis 
patients, also felt by the family such as role change appearance. Family and friends view the patient as a person 
who has limitations in his life, because hemodialisa will take time that can reduce the patient in social activities, 
and can lead to conflict, frustration, and guilt in the family. This limitation causes the hemodialysis patient to be 
susceptible to stress. That stress begins with an imbalance between individual claims and resources. The higher 
the gap occurs the higher the level of stress experienced by the individual. The state of stress can lead to 
physiological, psychological, and behavioral changes in the individual resulting in the development of an illness. 
4. Conclusion 
Cost Effectiveness Analysis (CEA) is a method designed to compare health outcomes and costs used to 
implement programs or interventions with other alternatives that result in the same outcomes. Cost analysis is 
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required to know all the details of the costs to be incurred and used. Hemodialysis service unit one of the 
services are quite expensive in patients with kidney failure, because it affected the price of medical supplies, 
drugs and consumables. Kidney failure is more common in adults, especially in the elderly. However, over time, 
kidney failure is also found in early childhood. The cause of high rates of kidney failure who undergo 
hemodialysis therapy in many factors affecting lifestyle changes, high-fat diet and carbohydrates, as well as 
other causes such as genetic diseases that are immune abnormalities and birth defects. 
Treatment of patients with renal failure with hemodialysis services is not as expensive as kidney transplant but 
because it has to be done continuously the cost of this treatment becomes very expensive. The problem that 
occurs today is when the number of patients and facilities are limited, so many patients who have to queue for 
dialysis. Because these limitations are difficult to overcome by the ability of government and community 
funding, the use of resources, especially the cost must be as effective and efficient as possible 
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